Asthma COPD

15 registered clinical trials studyying Asthma COPD — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Oscillometry and Machine Learning Approaches NCT07447596	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	—
Recruiting	Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Tri NCT07030881	First Affiliated Hospital of Ningbo University	N/A
Recruiting	FCV Vs VCV in Obstructive and Asthmatic Patients NCT06563544	Erasmus Medical Center	N/A
Completed	A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or NCT06172777	AstraZeneca	—
Recruiting	Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU NCT06538376	Brigham and Women's Hospital	N/A
Completed	Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD NCT06417931	University of Ibadan	N/A
Unknown	Clinical and Medico-economic Validation of the HEPHAI Solution. NCT06099145	Hephai	N/A
Completed	A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD NCT04233190	Eurofarma Laboratorios S.A.	Phase 3
Unknown	Relationship Between Acoustic Breath Sounds and Spirometry NCT06039943	University Hospital Birmingham	N/A
Completed	The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases NCT05764343	Recep Tayyip Erdogan University Training and Research Hospital	N/A
Unknown	The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill NCT05299385	Lifesemantics Corp.	Phase 3
Unknown	Phenotype Identification Based on Multimodal MRI Analysis of Patients With Bronchial Obstructive Diseases NCT04341701	University Hospital, Bordeaux	N/A
Completed	Single and Multiple Ascending Dose Study of KN-002 NCT05006521	Kinaset Therapeutics Inc	Phase 1
Completed	The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic NCT03858686	Foresee Pharmaceuticals Co., Ltd.	Phase 2
Completed	Impact of a Mobile Phone and Educational Intervention NCT06878898	Kent State University	N/A